Contract number: 43085381Additional Target Agreement • March 13th, 2019 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2019 Company Industry JurisdictionThis additional target agreement (the “ATA”) is made on December 31, 2018 (the “Effective Date”) under the terms and conditions herein by and between Boehringer Ingelheim International GmbH having a principal place of business at Binger Strasse 173, 55216 Ingelheim, Germany, (hereinafter referred to as “BOEHRINGER”), and Dicerna Pharmaceuticals Inc., 87 Cambridgepark Drive, Cambridge, MA 02140, USA (hereinafter referred to as “DICERNA”).